NAVCO Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 5, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	1	0	2	1	-	-
Market Cap Growth	-	-83.33%	41.44%	-	-	-
Enterprise Value	1	0	2	1	-	-
Last Close Price	0.01	0.01	0.03	0.03	-	-
PB Ratio	-0.61	-0.30	-2.00	13.84	-	-
P/TBV Ratio	-	-	-	23.90	-	-
Debt / Equity Ratio	-0.08	-0.09	-0.11	1.29	-1.14	-0.90
Net Debt / Equity Ratio	-0.08	-0.09	-0.10	-1.39	-1.14	-0.89
Net Debt / EBITDA Ratio	-	-4.33	-0.06	0.09	-2.13	-0.58
Net Debt / FCF Ratio	-3.35	-3.89	-0.35	0.07	-197.64	-0.91
Asset Turnover	-	-	-	-	0.17	-
Quick Ratio	0.00	0.00	0.08	0.37	0.06	0.06
Current Ratio	0.00	0.00	0.08	0.94	0.06	0.08
Return on Assets (ROA)	-104.53%	-84.39%	-195.20%	-143.33%	-83.25%	-
Return on Capital Employed (ROCE)	5.10%	5.60%	183.60%	-807.70%	65.80%	247.20%
Earnings Yield	-13.11%	-27.83%	-100.61%	-177.33%	-	-
FCF Yield	-	-7.49%	-14.79%	-146.69%	-	-
Buyback Yield / Dilution	-1.50%	-9.65%	-72.37%	-41.49%	-47.34%	-

Source: S&P Capital IQ. Standard template. Financial Sources.